García-Ruiz de Morales AG, Martínez-Sanz J, Vivancos-Gallego MJ, Sánchez-Conde M, Vélez-Díaz-Pallarés M, Romero-Hernández B, Vázquez MDG, de Luque CMC, González-Sarria A, Galán JC, Rodríguez FG, Moreno S, Pérez-Elías MJ.

HIV and HCV screening by non-infectious diseases physicians: can we improve testing and hidden infection rates?

Frontiers in Public Health 2023. 11: 1136988-1136988.

[doi:10.3389/fpubh.2023.1136988]

Velez-Diaz-Pallares, M, Esteban-Cartelle, B, Gramage-Caro, T, Montero-Llorente, B, Parro-Martin, MD, Rodriguez-Sagrado, MA, Alvarez-Diaz, AM.

Disorders in sleep quality associated with integrase inhibitors in the treatment of HIV

REVISTA ESPANOLA DE SALUD PUBLICA 2023. 97: .

Vélez-Díaz-Pallarés M, Esteban-Cartelle B, Gramage-Caro T, Montero-Llorente B, Parro-Martín MLÁ, Rodríguez-Sagrado MÁ, Álvarez-Díaz AM.

Trastornos en la calidad del sueño asociados a los inhibidores de la integrasa en el tratamiento del VIH.

REVISTA ESPANOLA DE SALUD PUBLICA 2023. 97: .

Rosas Cancio-Suárez M, Alonso C, Vivancos MJ, Pérez-Elías MJ, Cárdenas MJ, Vélez-Díaz-Pallarés M, Corbacho MD, Martín-Pedraza L, Muriel A, Martínez-Sanz J, Moreno S.

Impact of COVID-19 on the Care of Patients with HIV Infection.

Journal Of Clinical Medicine 2023. 12(12): .

[doi:10.3390/jcm12123882]

Quesada Muñoz L, Fernández-Fradejas J, Martinez-Barros H, Sánchez Cuervo M, Martín Rufo M, Pintor Recuenco MDR, Quereda Rodríguez-Navarro C, Álvarez-Díaz AM, Saez de la Fuente J.

Real-world effectiveness and factors associated with increased mortality in non-critically ill patients with COVID-19 pneumonia receiving remdesivir

EUROPEAN JOURNAL OF HOSPITAL PHARMACY 2023. : .

[doi:10.1136/ejhpharm-2023-003729]

Morillo Verdugo R, Bernardez Ferrán B, Fernández Polo A, Margusino Framiñan L, Martínez Sesmero JM, Velez-Diaz-Pallarés M, Vicente-Escrig E.

Prioritization of initiatives 2024-2027 of the strategic map of pharmaceutical outpatient care of the Spanish Society of Hospital Pharmacy.

FARMACIA HOSPITALARIA . : .

[doi:10.1016/j.farma.2024.03.013]

Martínez-Barros H, Pousada-Fonseca Á, Pedreira-Bouzas J, Clopés-Estela A.

Characteristics, clinical benefit and reimbursement of new authorisations for oncohaematology drugs in Spain between 2017 and 2020.

FARMACIA HOSPITALARIA . : .

[doi:10.1016/j.farma.2024.04.022]

Buti M, Calleja JL, Rodríguez MÁ, Domínguez-Hernández R, Cantero H, Espinoza-Cámac N, Casado MÁ.

Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D.

GASTROENTEROLOGIA Y HEPATOLOGIA . : 502241-502241.

[doi:10.1016/j.gastrohep.2024.502241]

Montero-Llorente B, Pérez Menéndez-Conde C, González Ferrer E, López Castellanos GT, Bedoya Del Olmo LM, Bermejo Vicedo T.

Impact of pharmaceutical care on hospital readmissions for heart failure: a randomised trial.

EUROPEAN JOURNAL OF HOSPITAL PHARMACY . : .

[doi:10.1136/ejhpharm-2024-004218]

Verdugo RM, Ferrán BB, Polo AF, Framiñan LM, Sesmero JMM, Velez-Diaz-Pallarés M, Vicente-Escrig E.

[Translated article] Prioritisation of 2024-2027 initiatives of the strategic Map for outpatient pharmaceutical care of the Spanish Society of Hospital Pharmacy.

FARMACIA HOSPITALARIA . : .

[doi:10.1016/j.farma.2024.08.003]